Unicycive Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Unicycive Therapeutics's balance sheet done over the years? Its assets were worth $14,191,000 last year, which is more than in the previous period. 127% of Unicycive Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $18,000,000, which means an increase by 448% compared compared to last year.

Debt to Assets

Unicycive Therapeutics, Inc. (NASDAQ:UNCY): Debt to assets
2019 19000 903K 4752.63%
2020 204000 2.87M 1409.31%
2021 18744000 2.26M 12.06%
2022 2818000 3.28M 116.54%
2023 14191000 18M 126.84%

UNCY Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
9.70M455K16.57M015K
Short term investments
00000
Net receivables
00000
Inventory
00000
Other current assets
3.69M2.18M1.83M4K4K
Total current assets
13.39M2.64M18.41M204K19K
Non-current assets:
Property, Plant and Equipment
792K174K333K00
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
0-174K-333K199.99K0
Total non-current assets
792K174K333K199.99K0
Total assets
14.19M2.81M18.74M204K19K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-18K0000
Short term debt
345K155K151K2.51M460K
Total current liabilities
17.53M3.28M2.10M2.87M903K
Non-current liabilities:
Long term debt
466K0155K00
Deferred tax
00000
Other non-current liabilities
01.04K000
Total non-current liabilities
466K1.04K155K00
Total liabilities
18M3.28M2.26M2.87M903K
Data sourceData sourceData source